Hanmi Pharm Co Ltd in Consumer Health (South Korea)
Hanmi Pharm Co Ltd is focused on research and the company aims to develop new medicines by reinforcing its existing research and the capacity in order to meet the needs of an ageing population by investing 14% of its annual turnover in research and development in 2016. As a result, the company sold licence for its ‘quantum project’, which involves the development of a potential medicine for diabetes, to Sanofi for EUR3,900 million in 2015, which resulted in a funding boost for the company’s rese...
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook